These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 3263685

  • 21. [The role of beta-lactamases and the permeability barrier in resistance to beta-lactam antibiotics].
    Perduca M, Pagani L, Romero E.
    Boll Ist Sieroter Milan; 1985; 64(4):281-4. PubMed ID: 3935134
    [Abstract] [Full Text] [Related]

  • 22. Broad spectrum beta-lactamases of Citrobacter diversus.
    Oliva B, Segatore B, Amicosante G, Franceschini N, Oratore A, Bennett PM.
    J Antimicrob Chemother; 1990 Mar; 25(3):335-41. PubMed ID: 2338412
    [Abstract] [Full Text] [Related]

  • 23. Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.
    Aronoff SC, Shlaes DM.
    J Infect Dis; 1987 May; 155(5):936-41. PubMed ID: 3104483
    [Abstract] [Full Text] [Related]

  • 24. Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment.
    Nikaido H, Normark S.
    Mol Microbiol; 1987 Jul; 1(1):29-36. PubMed ID: 3330755
    [Abstract] [Full Text] [Related]

  • 25. Resistance of Pseudomonas aeruginosa to beta-lactam antibiotics.
    Soto UL, Amador SM, Ramos FJ, Baca BE.
    Folia Microbiol (Praha); 1987 Jul; 32(4):290-6. PubMed ID: 3117650
    [Abstract] [Full Text] [Related]

  • 26. The permeability barrier of Haemophilus influenzae type b against beta-lactam antibiotics.
    Coulton JW, Mason P, Dorrance D.
    J Antimicrob Chemother; 1983 Nov; 12(5):435-49. PubMed ID: 6608514
    [Abstract] [Full Text] [Related]

  • 27. An explicit model for bacterial resistance: application to beta-lactam antibiotics.
    Waley SG.
    Microbiol Sci; 1987 May; 4(5):143-6. PubMed ID: 3153188
    [Abstract] [Full Text] [Related]

  • 28. The emergence of beta-lactam resistance among strains of Enterobacter cloacae and Pseudomonas aeruginosa.
    Aronoff SC.
    Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S100-3; discussion S128-32. PubMed ID: 2510122
    [Abstract] [Full Text] [Related]

  • 29. Mutations affecting the resistance of Escherichia coli K-12 to beta-lactam antibiotics.
    Hrebenda J, Heleszko H.
    J Antimicrob Chemother; 1985 Aug; 16(2):149-56. PubMed ID: 3905746
    [Abstract] [Full Text] [Related]

  • 30. Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future.
    Sanders CC, Sanders WE.
    Rev Infect Dis; 1983 Aug; 5(4):639-48. PubMed ID: 6353526
    [Abstract] [Full Text] [Related]

  • 31. Relationship between beta-lactamases production and resistance to beta-lactam antibiotics in clinical isolates of Enterobacteriaceae.
    Romero E, Pagani L, Perduca M, Mignatti P, Malfa S, Mills V.
    Microbiologica; 1984 Jul; 7(3):209-18. PubMed ID: 6334220
    [Abstract] [Full Text] [Related]

  • 32. Beta-lactam resistant Pseudomonas aeruginosa strains emerging during therapy: synergistic resistance mechanisms.
    Pagani L, Debiaggi M, Tenni R, Cereda PM, Landini P, Romero E.
    Microbiologica; 1988 Jan; 11(1):47-53. PubMed ID: 2832709
    [Abstract] [Full Text] [Related]

  • 33. Emergence of cross-resistance to imipenem and other beta-lactam antibiotics in Pseudomonas aeruginosa during therapy.
    Pagani L, Landini P, Luzzaro F, Debiaggi M, Romero E.
    Microbiologica; 1990 Jan; 13(1):43-53. PubMed ID: 2155376
    [Abstract] [Full Text] [Related]

  • 34. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH, Chan KC, Liu HB, Chung WH, Leung YC, Wong KY.
    Anal Chem; 2005 Aug 15; 77(16):5268-76. PubMed ID: 16097768
    [Abstract] [Full Text] [Related]

  • 35. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
    Shannon K, Phillips I.
    J Antimicrob Chemother; 1986 Dec 15; 18 Suppl E():15-22. PubMed ID: 3102451
    [Abstract] [Full Text] [Related]

  • 36. Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa.
    Livermore DM, Yang YJ.
    J Infect Dis; 1987 Apr 15; 155(4):775-82. PubMed ID: 3102630
    [Abstract] [Full Text] [Related]

  • 37. Effects of inducible beta-lactamase and antimicrobial resistance upon the activity of newer beta-lactam antibiotics against Pseudomonas aeruginosa.
    Hoffman TA, Cleary TJ, Bercuson DH.
    J Antibiot (Tokyo); 1981 Oct 15; 34(10):1334-40. PubMed ID: 6796556
    [Abstract] [Full Text] [Related]

  • 38. Contribution of chromosomal beta-lactamases to beta-lactam resistance in enterobacteria.
    Lindberg F, Normark S.
    Rev Infect Dis; 1986 Oct 15; 8 Suppl 3():S292-304. PubMed ID: 3529322
    [Abstract] [Full Text] [Related]

  • 39. A novel method for evaluating the outer membrane permeability to beta-lactamase-stable beta-lactam antibiotics.
    Kojo H, Shigi Y, Nishida M.
    J Antibiot (Tokyo); 1980 Mar 15; 33(3):310-6. PubMed ID: 6991466
    [Abstract] [Full Text] [Related]

  • 40. Interactions of formylamino- and methoxy-substituted beta-lactam antibiotics with beta-lactamases.
    Okonogi K, Sugiura A, Kuno M, Ono H, Harada S, Higashide E.
    J Antibiot (Tokyo); 1985 Nov 15; 38(11):1555-63. PubMed ID: 3878359
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.